Indefinite Delivery Contract 75N91019D00032

This Indefinite Delivery Contract was awarded by the National Cancer Institute (NCI), a civilian agency, to New York Genome Center, Inc. (Nygc) with a ceiling value of $149,173,285. The purpose of this IDIQ contract is to acquire genome characterization services consisting of large-scale, high-resolution, and comprehensive sequencing and array platforms including whole exome sequencing to support NCI's genomics research initiatives. The contract has a 5-year period of performance starting in...

The National Cancer Institute (NCI) has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the University of Southern California (USC) for Genome Characterization Center (GCC) services. The purpose of this contract is to acquire large-scale, high-resolution, and comprehensive sequencing and array platforms, including whole exome sequencing, to perform genomic, transcriptomic, and epigenomic characterizations of cancer-related alterations across multiple cancer types. The...

This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian federal agency, to Infinity Biologix LLC dba Sampled Division, a for-profit limited liability company. The contract, valued at up to $149,173,285, is for genome characterization center (GCC) services consisting of large-scale, high-resolution, and comprehensive sequencing and array platforms, including whole exome sequencing. The GCCs will receive cancer biomaterials and associated data from...

The National Cancer Institute (NCI), part of the National Institutes of Health within the Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Azenta US Inc., doing business as Brooks Life Sciences Inc., for the provision of genomic characterization services to support the NCI's Center for Cancer Genomics research programs. The IDIQ contract has a $49,832,452 ceiling value and a period of performance from August 31, 2019 through...

This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business. The purpose of this $149.17 million multiple-award IDC is to acquire genome characterization center (GCC) services for comprehensive sequencing and array platforms, including whole exome sequencing, to support NCI's cancer genomics research...

This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to The Broad Institute, Inc., a non-profit biomedical and genomic research organization. The $49.8 million IDC supports the NCI Genomic Characterization Centers and provides comprehensive genomic sequencing, data analysis, and other advanced computational biology services to NCI institutes and centers. Under the IDC, The Broad Institute has been awarded multiple task...

This single-award Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a small business subsidiary of Opko Health, Inc. The contract has a ceiling value of $2,530,960 and a period of performance through June 30, 2026. The contract is for Genedx to provide a wide range of genetic testing services to support NIH's clinical research and patient care programs. Services include mutation analysis, exome and genome sequencing, gene...

The National Institutes of Health National Cancer Institute awarded a single-award indefinite delivery contract to American Type Culture Collection to provide field and biospecimen support services. The contract has a potential value of $320 million and a period of performance from July 2022 to June 2027, with an option for additional task orders through June 2032. The contractor will perform services under five task areas to support the Division of Cancer Epidemiology and Genetics ongoing...

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to The GOG Foundation, Inc., a non-profit organization that provides administrative and operational support for cancer research programs. The $123,496.76 contract is part of the NCI Cancer Genome Atlas Program and involves the collection of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The GOG Foundation, Inc. will likely leverage its expertise in...

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $178,230 firm fixed-price delivery order is for the recovery and delivery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the agency's efforts to characterize the genomic changes in cancer....